Cite
Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study
MLA
Julia Lawrence, et al. “Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study.” Cancer Prevention Research, vol. 7, Jan. 2014, pp. 161–68. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d781e9eb9411e3aea7060196002174ac&authtype=sso&custid=ns315887.
APA
Julia Lawrence, Stephen R. Rapp, Heidi D. Klepin, Kaycee M. Sink, Hal H. Atkinson, Ann M. Geiger, Hanna Bandos, Mark A. Espeland, & Joseph P. Costantino. (2014). Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study. Cancer Prevention Research, 7, 161–168.
Chicago
Julia Lawrence, Stephen R. Rapp, Heidi D. Klepin, Kaycee M. Sink, Hal H. Atkinson, Ann M. Geiger, Hanna Bandos, Mark A. Espeland, and Joseph P. Costantino. 2014. “Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study.” Cancer Prevention Research 7 (January): 161–68. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d781e9eb9411e3aea7060196002174ac&authtype=sso&custid=ns315887.